This newest twist during the Lykos Therapeutics saga threatens A serious overhaul of the corporate’s tactic and route, with Musk ally and billionaire Trader Antonio Gracias showing to want to choose the corporate back again toward its nonprofit drug enhancement roots and a more Doblinite p